Press’ post set off a firestorm of controversy within the Haskell community, which is small but vocal, and likely felt the ...

This paper aims to forecast Chinese carbon prices by employing a range of predictors and analyzing their impact across ...

Recent discussion of artificial intelligence in intelligence analysis has consistently framed the technology as a means of accelerating an existing process. The intelligence cycle (collection, ...

Background Adult-onset Still’s disease (AOSD) is a systemic autoinflammatory disorder lacking a gold-standard diagnostic ...

Vitalik Buterin introduced the Lean Ethereum roadmap with major upgrades for security, privacy, and scalability. Developers support the plan but want faster progress. Meanwhile, Ethereum recorded a ...

Vitalik Buterin outlined an updated “Lean Ethereum” roadmap that aims to overhaul nearly every major part of the network over three to four years while minimizing disruption to existing applications.

The Council for the Indian School Certificate Examinations (CISCE) has released the ISC Computer Science (Subject Code - 868) for the Year 2027 evaluation cycle. It is designed specifically to make ...

Forbes contributors publish independent expert analyses and insights. Dr. Lance B. Eliot is a world-renowned AI scientist and consultant. In today’s column, I examine the belief that AI will ...

AI technology - Read all the latest news headline updates on AI technology. Get all the AI technology breaking news updates, videos, photostories and more at Business Standard.

Recursion Pharmaceuticals is trying to solve a serious problem. Even with technological improvements, the time and costs required to develop brand-new drugs have increased in recent decades. It can ...

In a recent social media post, Peter Ray, senior director of medicinal chemistry at Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), drew attention to a new article in WIRED from Veronique Greenwood ...

As of March 31, Recursion Pharmaceuticals had a cash position of $509 million. Following Tuesday’s layoffs, the biotech expects its runway to last into the fourth quarter of 2027. Recursion ...